Viral Hepatitis: Hepatitis A and E

2016 ◽  
pp. 121-131
Author(s):  
Adnan Said ◽  
Amanda DeVoss
Keyword(s):  
Viral Hepatitis ◽  
Hepatitis A

Salivary and Serum Biochemical Alterations in Patients with Acute Viral Hepatitis

2018 ◽  
Vol 69 (3) ◽  
pp. 747-751 ◽  
Author(s):  
Daniela Gabriela Badita ◽  
Iulia Ioana Stanescu ◽  
Andra Balcangiu Stroescu ◽  
Dan Piperea Sianu ◽  
Daniela Miricescu ◽  
...  
Keyword(s):  
Viral Hepatitis ◽  
Hepatitis A ◽  
Hepatitis A Virus ◽  
World Population ◽  
Major Health Problem ◽  
Major Health ◽  
Biochemical Alterations ◽  
B Virus ◽  
Serum Biochemical ◽  
Viral Hepatitis A

Viral hepatitis represents a major health problem worldwide. Approximately 1.4 million people are infected with hepatitis A virus every year, although given that most of the cases evolve asymptomatically the real number could be even higher. At the same time, hepatitis B virus affects up to 30% of the world population and represents one of the main causes of cirrhosis and hepatocellular carcinoma. Thus, it is very important to understand the physiopathology of viral hepatitis A and B not only for the diagnosis, but also for the therapeutic protocol. The present research aimed to determine if HAV and HBV can alter serum and salivary levels of total protein and of 2 important electrolytes: calcium and potassium.

CHRONIC HCV-INFECTION AS A PREDICTOR OF DISEASE SEVERITY (case study)

2020 ◽  
pp. 79-82
Author(s):  
Nataliia Volodymyrivna Shepylieva ◽  
Alla Oleksandrivna Shvaichenko
Keyword(s):  
Viral Hepatitis ◽  
Hepatitis A ◽  
Health Sector ◽  
Global Strategy ◽  
Hcv Infection ◽  
Viral Hepatitis C ◽  
Incidence And Mortality ◽  
Chronic Hcv Infection ◽  
Chronic Hcv ◽  
Viral Hepatitis A

A global problem for humanity is the wide spread of HCV carriers worldwide. To address this, the WHO has developed a global strategy for the health sector to eliminate viral hepatitis and has set the following goals: to reduce the number of new cases of chronic hepatitis B and C by 90 % by 2030 as well as to reduce the quantity of death from these infections by 65 %. It is emphasized that the development of infectious or somatic disease on the background of chronic viral hepatitis requires a more careful approach and thorough medical correction, as their course and prognosis can be significantly aggravated. The case of viral hepatitis A, which occurred on a background of previously undiagnosed HCV infection and resulted in a death, has been described. Thus, previously undiagnosed HCV infection exacerbated the course of a self−eliminating disease, such as hepatitis A, and resulted in a death. Therefore, expanding the screening for viral hepatitis will allow identifying infected individuals and conducting antiviral therapy and preventive measures, which will reduce the incidence and mortality rates. Key words: viral hepatitis A, viral hepatitis C, chronic HCV−infection, diagnosis, treatment, outcome.

scholarly journals Changing Trends in Viral Hepatitis-Associated Hospitalizations in the American Indian/Alaska Native Population, 1995–2007

2011 ◽  
Vol 126 (6) ◽  
pp. 816-825 ◽  
Author(s):  
Kathy K. Byrd ◽  
John T. Redd ◽  
Robert C. Holman ◽  
Dana L. Haberling ◽  
James E. Cheek
Keyword(s):  
Health Care ◽  
Hepatitis C ◽  
Hepatitis B ◽  
American Indian ◽  
Viral Hepatitis ◽  
Alaska Native ◽  
Hepatitis A ◽  
Hospitalization Rate ◽  
Time Periods ◽  
Significant Change

Objective. We described the changing epidemiology of viral hepatitis among the American Indian/Alaska Native (AI/AN) population that uses Indian Health Service (IHS) health care. Methods. We used hospital discharge data from the IHS National Patient Information Reporting System to determine rates of hepatitis A-, B-, and C-associated hospitalization among AI/ANs using IHS health care from 1995–2007 and summary periods 1995–1997 and 2005–2007. Results. Hepatitis A-associated hospitalization rates among AI/AN people decreased from 4.9 per 100,000 population during 1995–1997 to 0.8 per 100,000 population during 2005–2007 (risk ratio [RR] = 0.2, 95% confidence interval [CI] 0.1, 0.2). While there was no significant change in the overall hepatitis B-associated hospitalization rate between time periods, the average annual rate in people aged 45–64 years increased by 109% (RR=2.1, 95% CI 1.4, 3.2). Between the two time periods, the hepatitis C-associated hospitalization rate rose from 13.0 to 55.0 per 100,000 population (RR=4.2, 95% CI 3.8, 4.7), an increase of 323%. The hepatitis C-associated hospitalization rate was highest among people aged 45–64 years, males, and those in the Alaska region. Conclusions. Hepatitis A has decreased to near-eradication levels among the AI/AN population using IHS health care. Hepatitis C-associated hospitalizations increased significantly; however, there was no significant change in hepatitis B-associated hospitalizations. Emphasis should be placed on continued universal childhood and adolescent hepatitis B vaccination and improved vaccination of high-risk adults. Prevention and education efforts should focus on decreasing hepatitis C risk behaviors and identifying people with hepatitis C infection so they may be referred for treatment.

Viral Hepatitis: 1985 Update

1985 ◽  
Vol 7 (1) ◽  
pp. 3-11
Author(s):  
Saul Krugman
Keyword(s):  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Viral Hepatitis ◽  
Hepatitis A ◽  
Viral Infections ◽  
Hepatitis A Virus ◽  
Fatal Outcome ◽  
Specific Marker ◽  
Hepatitis D ◽  
B Virus

During the past two decades extraordinary advances in hepatitis research have clarified the etiology and natural history of the disease. At least four types of hepatitis have been identified: A, B, D (delta), and non-A, non-B. Hepatitis A virus (HAV), hepatitis B virus (HBV), and hepatitis D virus (HDV) have been characterized. Serologic tests have been developed to detect the antigens and antibodies associated with these three hepatitis infections. As of the present time, the non-A, non-B viral agents have not been identified. Therefore, non-A, non-B hepatitis is diagnosed by excluding other viral causes of hepatitis, such as hepatitis A virus, hepatitis B virus, Epstein-Barr virus (EBV), cytomegalovirus (CMV), and others. A recent report indicating that non-A, non-B hepatitis may be caused by a retrovirus, if confirmed, may provide a specific marker of this infection. The course of viral hepatitis is variable; it may be an asymptomatic, anteric infection, or it may be an acute illness characterized by fever, malaise, anorexia, nausea, abdominal pain, and jaundice. Most patients recover completely, but occasionally the infection may be complicated by chronic hepatitis, cirrhosis, and, occasionally, by a fulminant fatal outcome. This review will be devoted predominantly to a discussion of the diagnostic and prophylactic aspects of hepatitis A and hepatitis B viral infections.

scholarly journals Viral Hepatitis: Retrospective Review in a Canadian Pediatric Hospital

2011 ◽  
Vol 2011 ◽  
pp. 1-4 ◽  
Author(s):  
Paulina Cybulska ◽  
Andy Ni ◽  
Carolina Jimenez-Rivera
Keyword(s):  
Viral Hepatitis ◽  
Epstein Barr Virus ◽  
Hepatitis A ◽  
Chart Review ◽  
Clinical Presentation ◽  
Retrospective Chart Review ◽  
Barr Virus ◽  
Mild Abdominal Pain ◽  
Epstein Barr ◽  
Acute And Chronic Hepatitis

Introduction. Clinical presentation of viral hepatitis ranges from mild symptoms to fulminant hepatitis. Our aim is to describe clinical presentation and outcomes of children with viral hepatitis from the Eastern Ontario/Western Quebec regions of Canada. Methods. Retrospective chart review of children diagnosed with viral hepatitis at our institution from January 1, 1998, to December 31, 2007. Results. There were 261 charts reviewed, only 64 had a confirmed viral etiology: 34 (53%) hepatitis B (HBV), 16 (25%) hepatitis C (HCV), 4 (6.3%) hepatitis A (HAV), 7 (11%) cytomegalovirus (CMV), and 3 (4.7%) Epstein-Barr virus (EBV). Children with HBV presented at a mean age of 6.4±4.6 years. Spontaneous seroconversion (appearance of HBVeAb and loss of HBVeAg) occurred in 21/34 (61.7%). Children with acute hepatitis (HAV, CMV, and EBV) presented with mild abdominal pain, jaundice, and fevers. Overall outcome was excellent. Conclusion. Acute and chronic hepatitis in children has a benign course; moreover, HBV spontaneous seroconversion is common in pediatric patients.

scholarly journals General Epidemiological Parameters of Viral Hepatitis A, B, C, and E in Six Regions of China: A Cross-Sectional Study in 2007

PLoS ONE ◽  
2009 ◽  
Vol 4 (12) ◽  
pp. e8467 ◽  
Author(s):  
Jian Lu ◽  
Yongdong Zhou ◽  
Xiaojing Lin ◽  
Yongzhen Jiang ◽  
Ruiguang Tian ◽  
...  
Keyword(s):  
Viral Hepatitis ◽  
Hepatitis A ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional ◽  
Viral Hepatitis A ◽  
Epidemiological Parameters

Viral Hepatitis, A Through E, In Pregnancy

2009 ◽  
pp. 353-373
Author(s):  
Eashen Liu ◽  
Jacqueline Laurin
Keyword(s):  
Viral Hepatitis ◽  
Hepatitis A ◽  
Viral Hepatitis A ◽  
In Pregnancy

scholarly journals Type A viral hepatitis: A summary and update on the molecular virology, epidemiology, pathogenesis and prevention

2018 ◽  
Vol 68 (1) ◽  
pp. 167-184 ◽  
Author(s):  
Stanley M. Lemon ◽  
Jördis J. Ott ◽  
Pierre Van Damme ◽  
Daniel Shouval
Keyword(s):  
Viral Hepatitis ◽  
Hepatitis A ◽  
Type A ◽  
Molecular Virology ◽  
Viral Hepatitis A

scholarly journals Increase in hepatitis A cases in the Czech Republic in 2008 - preliminary report

2008 ◽  
Vol 13 (40) ◽  
Author(s):  
K Fabianova ◽  
J Cástková ◽  
C Beneš ◽  
J Kyncl ◽  
B Kriz
Keyword(s):  
Public Health ◽  
Czech Republic ◽  
Viral Hepatitis ◽  
Preliminary Report ◽  
Hepatitis A ◽  
Health Protection ◽  
The Czech Republic ◽  
The Public ◽  
Viral Hepatitis A ◽  
Public Health Protection

The public health protection authorities in the Czech Republic report a rise in cases of viral hepatitis A (HAV) since the end of May 2008. In total, as many as 602 HAV cases have been reported in 2008 until the end of calendar week 39 (28 September).

Sign in / Sign up

Export Citation Format

Share Document